Literature DB >> 33585527

Stabilization of a Broadly Neutralizing Anti-Chikungunya Virus Single Domain Antibody.

Jinny L Liu1, Emily M Webb2, Dan Zabetakis1, Crystal W Burke3, Christina L Gardner3, Pamela J Glass3, Patricia M Legler1, James Weger-Lucarelli2, George P Anderson1, Ellen R Goldman1.   

Abstract

A single domain antibody (clone CC3) previously found to neutralize a vaccine strain of the chikungunya virus (PRNT50 = 2. 5 ng/mL) was found to be broadly neutralizing. Clone CC3 is not only able to neutralize a wild-type (WT) strain of chikungunya virus (CHIKV), but also neutralizes WT strains of Mayaro virus (MAYV) and Ross River virus (RRV); both arthralgic, Old World alphaviruses. Interestingly, CC3 also demonstrated a degree of neutralizing activity against the New World alphavirus, Venezuelan equine encephalitis virus (VEEV); albeit both the vaccine strain, TC-83, and the parental, WT Trinidad donkey strain had PRNT50 values ~1,000-fold higher than that of CHIKV. However, no neutralization activity was observed with Western equine encephalitis virus (WEEV). Ten CC3 variants designed to possess a range of isoelectric points, both higher and lower, were constructed. This approach successfully identified several lower pI mutants which possessed improved thermal stabilities by as much as 10°C over the original CC3 (Tm = 62°C), and excellent refolding abilities while maintaining their capacity to bind and neutralize CHIKV.
Copyright © 2021 Liu, Webb, Zabetakis, Burke, Gardner, Glass, Legler, Weger-Lucarelli, Anderson and Goldman.

Entities:  

Keywords:  alphavirus; chikungunya virus; melting temperature; neutralization; new world; old world; single domain antibody

Year:  2021        PMID: 33585527      PMCID: PMC7876468          DOI: 10.3389/fmed.2021.626028

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  36 in total

1.  The functional capacity of the natural amino acids for molecular recognition.

Authors:  Sara Birtalan; Robert D Fisher; Sachdev S Sidhu
Journal:  Mol Biosyst       Date:  2010-04-09

Review 2.  Nanobodies: natural single-domain antibodies.

Authors:  Serge Muyldermans
Journal:  Annu Rev Biochem       Date:  2013-03-13       Impact factor: 23.643

Review 3.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

4.  Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease.

Authors:  M M Harmsen; C B van Solt; H P D Fijten; L van Keulen; R A Rosalia; K Weerdmeester; A H M Cornelissen; M G M De Bruin; P L Eblé; A Dekker
Journal:  Vet Microbiol       Date:  2006-10-28       Impact factor: 3.293

5.  Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model.

Authors:  Christopher H Logue; Christopher F Bosio; Thomas Welte; Kimberley M Keene; Jeremy P Ledermann; Aaron Phillips; Brian J Sheahan; Dennis J Pierro; Nicole Marlenee; Aaron C Brault; Catharine M Bosio; Amber J Singh; Ann M Powers; Ken E Olson
Journal:  J Gen Virol       Date:  2009-04-29       Impact factor: 3.891

6.  Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points.

Authors:  M Arbabi-Ghahroudi; R To; N Gaudette; T Hirama; W Ding; R MacKenzie; J Tanha
Journal:  Protein Eng Des Sel       Date:  2008-11-24       Impact factor: 1.650

Review 7.  Single-Domain Antibodies As Therapeutics against Human Viral Diseases.

Authors:  Yanling Wu; Shibo Jiang; Tianlei Ying
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

8.  Comparative analysis of nanobody sequence and structure data.

Authors:  Laura S Mitchell; Lucy J Colwell
Journal:  Proteins       Date:  2018-04-15

9.  Prophylaxis and therapy for Chikungunya virus infection.

Authors:  Thérèse Couderc; Nassirah Khandoudi; Marc Grandadam; Catherine Visse; Nicolas Gangneux; Sébastien Bagot; Jean-François Prost; Marc Lecuit
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

Review 10.  Recombinant expression of nanobodies and nanobody-derived immunoreagents.

Authors:  Ario de Marco
Journal:  Protein Expr Purif       Date:  2020-04-11       Impact factor: 1.650

View more
  1 in total

1.  Bivalent single domain antibody constructs for effective neutralization of Venezuelan equine encephalitis.

Authors:  Jinny L Liu; Dan Zabetakis; Christina L Gardner; Crystal W Burke; Pamela J Glass; Emily M Webb; Lisa C Shriver-Lake; George P Anderson; James Weger-Lucarelli; Ellen R Goldman
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.